Vignesh T. Packiam, MD

Vignesh T. Packiam, MD, of Rutgers Cancer Institute

Articles by Vignesh T. Packiam, MD

AI-Powered Biomarkers and Precision Medicine in High-Risk NMIBC

Vignesh T. Packiam, MDNon-Muscle Invasive Urothelial Carcinoma | February 11, 2025

Drs. Nizam and Packiam review the findings from a study on AI-powered biomarkers to aid NMIBC diagnosis and treatment.

Sequential Endoluminal Chemotherapy for Non-Invasive High-Grade UTUC

Vignesh T. Packiam, MDUpper Tract Urothelial Carcinoma | June 26, 2024

Drs. Packiam and Murray weigh multiple studies exploring gemcitabine/docetaxel as a frontline therapy for UTUC.

Addressing the BCG Shortage: Gemcitabine/Docetaxel Is an Effective Substitute Treatment for NMIBC

Vignesh T. Packiam, MDNon-Muscle Invasive Urothelial Carcinoma | March 24, 2023

Vignesh T. Packiam, MD discusses the current BCG shortage as well as potential substitutes such as gemcitabine and docetaxel.